Patents by Inventor Jin Wook TAK

Jin Wook TAK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR PREPARING ORAL COMPOSITE TABLET CONTAINING PROTON PUMP INHIBITOR AND ANTACID AND ORAL COMPOSITE TABLET PREPARED THEREBY
    Publication number: 20250032420
    Abstract: A method for preparing an oral composite tablet containing a proton pump inhibitor and an antacid and an oral composite tablet prepared by the method are disclosed. The method prepare an oral composite tablet with excellent appearance stability and high productivity. The proton pump inhibitor includes esomeprazole, omeprazole, lansoprazole, rabeprazole, pantoprazole, or combinations thereof.
    Type: Application
    Filed: December 6, 2022
    Publication date: January 30, 2025
    Applicant: HANMI PHARM. CO., LTD.
    Inventors: Jin Wook TAK, Young II KIM, Taek Kwan KWON, Ho Taek IM, Yong II KIM
  • ORAL COMPLEX TABLET COMPRISING SITAGLIPTIN, DAPAGLIFLOZIN, AND METFORMIN
    Publication number: 20240325311
    Abstract: An oral dosage form in a form of a bi-layer complex tablet is disclosed. The bi-layer oral complex tablet contains colloidal silicon dioxide in an amount of 0.5 to 2% by weight based on a total weight of the first layer. A method for manufacturing the bi-layer oral complex tablet dosage form is also disclosed.
    Type: Application
    Filed: June 27, 2022
    Publication date: October 3, 2024
    Applicant: HANMI PHARM. CO., LTD.
    Inventors: Jin Wook TAK, Ji Won BAEK, Taek Kwan KWON, Ho Taek IM, Yong II KIM
  • COMPOSITE FORMULATION COMPRISING SITAGLIPTIN AND DAPAGLIFLOZIN AND PREPARATION METHOD THEREFOR
    Publication number: 20230255890
    Abstract: Provided are a composite formulation including sitagliptin and dapagliflozin and a method of preparing the same.
    Type: Application
    Filed: April 29, 2021
    Publication date: August 17, 2023
    Applicant: HANMI PHARM. CO., LTD.
    Inventors: Bo Sik KIM, Jin Wook TAK, Jung Hyun CHO, Ho Taek IM, Yong II KIM
  • ORAL COMPLEX TABLET COMPRISING SITAGLIPTIN, DAPAGLIFLOZIN, AND METFORMIN
    Publication number: 20230149314
    Abstract: According to an aspect, provided are a composite tablet and a method of preparing the composite tablet, wherein the composite tablet may include a first layer including dry granules that include sitagliptin or a pharmaceutically acceptable salt thereof, or a hydrate thereof, and dapagliflozin or a pharmaceutically acceptable salt thereof, or a hydrate thereof, and a second layer including wet granules that include metformin or a pharmaceutically acceptable salt thereof and colloidal silicon dioxide.
    Type: Application
    Filed: March 12, 2021
    Publication date: May 18, 2023
    Applicant: HANMI PHARM. CO., LTD.
    Inventors: Jin Wook TAK, Bo Sik KIM, Taek Kwan KWON, Ho Taek IM, Yong II KIM
  • COMPOSITE CAPSULE PREPARATION CONTAINING TADALAFIL AND TAMSULOSIN AND HAVING IMPROVED STABILITY AND ELUTION RATE
    Publication number: 20190125685
    Abstract: One aspect of the present invention provides: a composite capsule preparation containing tadalafil or a pharmaceutically acceptable salt thereof and tamsulosin or a pharmaceutically acceptable salt thereof, wherein the composite capsule preparation comprises, on the surface thereof, a film coating layer comprising, as a film coating material, polyvinyl alcohol (PVA) or a copolymer comprising PVA; and a preparation method therefor.
    Type: Application
    Filed: March 31, 2017
    Publication date: May 2, 2019
    Applicant: HANMI PHARM. CO., LTD.
    Inventors: Jin Wook TAK, Jung Hyun CHO, Jin Cheul KIM, Yong Il KIM, Jae Hyun PARK, Jong Soo WOO